Get started
Author

Rhonda K. Meredith

Observed name: Rhonda Meredith
OpenAlex ID: A5043883006
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
2021 · Lauren Brady, Michelle Kriner, et al. · Nature Communications · 299
PDF
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies
2018 · Jinho Lee, Gary K. Geiss, et al. · Molecular & Cellular Proteomics · 23
Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer
2017 · Daniel J. O'Shannessy, Katie Bendas, et al. · Genomics · 18
PDF
A complete pipeline for high‐plex spatial proteomic profiling and analysis of neural cell phenotypes on the CosMx™ Spatial Molecular Imager and AtoMx™ Spatial Informatics Platform
2023 · Alyssa Rosenbloom, Shilah Bonnett, et al. · Alzheimer s & Dementia · 4
PDF
Abstract 3878: Subcellular characterization of over 100 proteins in FFPE tumor biopsies with CosMx Spatial Molecular Imager
2022 · Zachary R. Lewis, Tien Phan-Everson, et al. · Cancer Research · 4
Interferon-γ induces distinct mRNA and protein profiles in acute and chronic myeloid leukemia
2017 · Jayakumar Vadakekolathu, Rhonda Meredith, et al. · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) · 3
Abstract 4617: A complete pipeline for high-plex spatial proteomic profiling and analysis on the cosmxtm spatial molecular imager and atomtm spatial informatics platform
2023 · Tien Phan-Everson, Zachary Lewis, et al. · Cancer Research · 1
Abstract 5641: Single cell spatial molecular imaging of 76-plex proteins in clinical cancer samples in response to personalized treatment
2023 · Zachary R. Lewis, Brian Birditt, et al. · Cancer Research · 1
Analysis of molecular and protein signatures on farletuzumab pharmacokinetics from a phase 3 ovarian cancer study.
2016 · Daniel John O'Shannessy, Charles Schweizer, et al. · Journal of Clinical Oncology · 1
Abstract 3649: A novel spatial multi-omic approach for biological discoveries in colonic diseased tissues using a comprehensive Immuno-Oncology Proteome Atlas and Whole Transcriptome Atlas
2024 · Alyssa Rosenbloom, Shilah Bonnett, et al. · Cancer Research
207 The spatially-resolved proteomic atlas of the tumor immune architecture of HER2-positive breast cancer and response to neoadjuvant anti-HER2 therapy-based chemotherapy
2023 · Saranya Chumsri, Jennifer Kachergus, et al. · Regular and Young Investigator Award Abstracts
PDF
120 Human immuno-oncology proteome atlas enables a holistic proteomic approach for spatial biology discovery in FFPE tissues
2023 · Alyssa Rosenbloom, Shilah Bonnett, et al. · Regular and Young Investigator Award Abstracts
PDF
147 Comprehensive in situ immune phenotyping with the CosMx™ high plex protein assay
2022 · Tien Phan-Everson, Jianji Chen, et al. · Regular and Young Investigator Award Abstracts
PDF
Simultaneous Detection of Single Nucleotide Variants and Expression of RNA and Protein in Multiple Myeloma Bone Marrow Aspirates
2017 · David G. Coffey, Katherine A. Lombardo, et al. · Blood
Absence of the non-coding RNA BC1 disrupts spine morphology, experience-dependent plasticity and learning
2016 · Víctor Briz, Emanuela Pasciuto, et al.
NGS-based targeted RNA sequencing for expression profiling and relative quantitation of specific gene isoforms and fusions in tumor-specific panels.
2013 · Gordon Vansant, Mark Landers, et al. · Journal of Clinical Oncology
Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples.
2012 · Mark Landers, Rhonda Meredith, et al. · Journal of Clinical Oncology
Abstract 4851: A single-tube protocol for next gen library construction increases complexity and simplifies parallel sample handling
2011 · Kyusung Park, Xiaoping Duan, et al. · Cancer Research
Works count: 18
Citation count: 353
H-index: 4
I10-index: 3
Year
Topic
Type